Published on
September 5, 2024
- 14:00 GMT
![](https://img.einpresswire.com/small/734763/20-15-visioneers-logo.png)
StableBody Technologies & Quine Biologics Adopt 20/15 Visioneers’ PythiaAI™ GenAI Framework to Enhance Antibody Design
Adoption of the PythiaAI™ Agentic LLM framework allowed for the Discovery of Novel Therapeutics in Record Time and Efficiency HEREFORD, PA, UNITED STATES, September 5, 2024 /EINPresswire.com/ -- Today, StableBody Technologies and Quine Biologics …
Distribution channels:
Agriculture, Farming & Forestry Industry, Consumer Goods
...